Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics Inc.(MLYS) | 2,016,822 | 3,127,933 | +1,111,111 | 24,827 | 49,672 | 12.76% | +24,844 |
| ARS Pharmaceuticals, Inc. | 4,012,903 | 4,012,903 | 0 | 42,336 | 50,482 | 12.97% | +8,146 |
| Oculis Holding AG | 0 | 322,500 | +322,500 | 0 | 6,137 | 1.58% | +6,137 |
| KALA Bio, Inc. | 598,940 | 598,940 | 0 | 4,157 | 3,432 | 0.88% | -725 |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 4,911,539 | 0 | 40,226 | 38,801 | 9.97% | -1,424 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 4,973 | 3,350 | 0.86% | -1,623 |
| Nkarta, Inc. | 3,333,333 | 3,333,333 | 0 | 8,300 | 6,133 | 1.58% | -2,167 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 15,405 | 12,034 | 3.09% | -3,371 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 8,344 | 4,415 | 1.13% | -3,929 |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | 41,287 | 35,696 | 9.17% | -5,591 |
| Design Therapeutics, Inc. | 6,526,476 | 6,526,476 | 0 | 40,268 | 25,192 | 6.47% | -15,076 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 179,963 | 153,939 | 39.54% | -26,024 |